The Protective Role of Immunomodulators on Tissue-Type Plasminogen Activator-Induced Hemorrhagic Transformation in Experimental Stroke: A Systematic Review and Meta-Analysis
Background: Recanalization with tissue plasminogen activator (tPA) is the only approved agent available for acute ischemic stroke. But delayed treatment of tPA may lead to lethal intracerebral hemorrhagic transformation (HT). Numerous studies have reported that immunomodulators have good efficacy on...
Saved in:
Main Authors: | Yang Ye (Author), Yu-Tian Zhu (Author), Hong-Xuan Tong (Author), Jing-Yan Han (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
QiShenYiQi Inhibits Tissue Plasminogen Activator-Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice
by: Yang Ye, et al.
Published: (2022) -
Role of Tissue-Type Plasminogen Activator in Ischemic Stroke
by: Yasuhiro Suzuki
Published: (2010) -
Neutrophilic noncoding RNAs predict outcomes of acute ischemic stroke patients treated with recombinant tissue plasminogen activator
by: Ziping Han, et al.
Published: (2022) -
Hemorrhagic Transformation in Stroke
by: Dianarelys Villafuerte Delgado, et al.
Published: (2016) -
Hemorrhagic Transformation in Stroke
by: Dianarelys Villafuerte Delgado, et al.
Published: (2016)